You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydroxychloroquine

Showing 1 - 25 of 727
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hydroxychloroquine May be Beneficial for Preeclampsia

Not yet recruiting
  • Pre-Eclampsia
  • Hydroxychloroquine
  • (no location specified)
Aug 27, 2023

Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)

Recruiting
  • Inflammatory Cardiomyopathy
  • Myocarditis
  • Wuhan, Hubei, China
    Tongji Hospital
Jul 18, 2023

Novel ERG for Detection of Hydroxychloroquine Retinopathy

Not yet recruiting
  • Hydroxychloroquine Retinopathy
  • Hand-Held Full-Field Skin-Electrode Electroretinography (Device to be evaluated)
  • +3 more
  • (no location specified)
Sep 6, 2023

Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

Not yet recruiting
  • Hydroxychloroquine
  • +2 more
  • Hydroxychloroquine Combined With Gemcitabine
  • (no location specified)
Dec 3, 2022

Individuals Undergoing Cardiac and General Surgery Trial in Durham (Hydroxychloroquine)

Recruiting
  • Individuals Undergoing Cardiac and General Surgery
  • Hydroxychloroquine
  • Durham, North Carolina
    Duke Health
Dec 1, 2022

Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

Withdrawn
  • Solid Tumor
  • Advanced Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Recruiting
  • Nonalcoholic Steatohepatitis
  • hydroxychloroquine
  • Taipei, Taiwan
  • +1 more
Feb 8, 2023

Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

Recruiting
  • Graves Ophthalmopathy
  • Hydroxychloroquine
  • Hsinchu, Taiwan
  • +1 more
Dec 1, 2022

Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)

Not yet recruiting
  • Pericarditis Idiopathic Recurrent
  • Athens, Attiki, Greece
    "Hippokration" General Hospital of Athens
Feb 20, 2023

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Hydroxychloroquine
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)

Not yet recruiting
  • Interstitial Lung Disease
  • Surfactant Dysfunction
  • Hydroxychloroquine
  • Shanghai, Shanghai, China
    Children's hospital of Fudan University
Jan 9, 2023

Clarifying Misbeliefs About Hydroxychloroquine:

Not yet recruiting
  • Lupus
  • Decision-making tool
  • Questionnaire
  • Madison, Wisconsin
    University of Wisconsin
Jun 19, 2023

LPIN1 Mutations Treated With Low Dose Hydroxychloroquine Sulfate

Not yet recruiting
  • Lipin-1 Deficiency
    • (no location specified)
    Sep 29, 2022

    Breast Cancer, Gynecologic Cancer, Early-stage Breast Cancer Trial in Tucson (Hydroxychloroquine)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Hydroxychloroquine
    • Tucson, Arizona
      University of Arizona Cancer Center
    Jan 9, 2023

    Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))

    Recruiting
    • Hepatocellular Cancer
    • Sorafenib (SOR)
    • Hydroxychloroquine (HCQ)
    • San Antonio, Texas
      University of Texas Health Cancer Center
    Sep 16, 2022

    Arthritis, Arthralgia Trial in Edmonton (Hydroxychloroquine, Placebo)

    Recruiting
    • Arthritis
    • Arthralgia
    • Hydroxychloroquine
    • Placebo
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jan 17, 2023

    Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)

    Terminated
    Has Results
    • Diabetes Mellitus Type 2 With Hyperglycemia
    • Los Angeles, California
      Charles Drew University of Medicine and Science
    Sep 23, 2022

    COVID-19 Trial in São Paulo (Hydroxychloroquine Sulfate, Azithromycin Tablets)

    Suspended
    • COVID-19
    • Hydroxychloroquine Sulfate
    • Azithromycin Tablets
    • São Paulo, Brazil
      Prevent Senior Private Operadora de Saúde LTDA.
    Nov 3, 2022

    Covid-19 Trial in São Paulo (Hydroxychloroquine Sulfate, Azithromycin Tablets)

    Suspended
    • Covid-19
    • Hydroxychloroquine Sulfate
    • Azithromycin Tablets
    • São Paulo, Brazil
      Prevent Senior Private Operadora de Saúde LTDA.
    Nov 3, 2022

    Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

    Recruiting
    • Metastatic Pancreatic Carcinoma
    • +6 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Oct 31, 2022

    Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

    Recruiting
    • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
    • +2 more
    • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
    • Chicago, Illinois
      Northwestern University
    Nov 16, 2022

    Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

    Active, not recruiting
    • Gastrointestinal Cancer
    • New York, New York
    • +1 more
    Nov 29, 2022

    Prostate Cancer Recurrent, Solid Tumor, Adult Trial in Charleston (Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine,

    Recruiting
    • Prostate Cancer Recurrent
    • Solid Tumor, Adult
    • Hydroxychloroquine, Metformin, Sirolimus
    • +3 more
    • Charleston, South Carolina
      Medical University of South Carolina
    Apr 4, 2022

    Healthy Trial in Groningen (Nipocalimab, Etanercept, Hydroxychloroquine)

    Completed
    • Healthy
    • Groningen, Netherlands
      PRA Health Sciences
    Jul 5, 2022

    Rheumatic Diseases Trial in San Francisco (New e-prescribing interface)

    Active, not recruiting
    • Rheumatic Diseases
    • New e-prescribing interface
    • San Francisco, California
      University of California, San Francisco
    Nov 29, 2022